Module 2: Optimizing Efficiency and Effectiveness in Translational Research: Infrastructure, Teams and Partnerships, and Scientific Approaches
Module overview
What you will learn
Module 2 showcases the partners inside and outside of NCATS who contributed to the metarrestin project and the varied disciplines that were essential to advance the project, with a deep dive into biology. These lectures highlight the role of novelty and innovation throughout the metarrestin project and the critical importance of the institutional environment in the NCATS internal labs, which enabled the cross sectoral partnerships, cross-disciplinary team science, and tolerance for risk taking that were essential to the success of this project.
Lecturers
Matthew D. Hall, Ph.D.
Senior Scientist, Division of Preclinical Innovation, NCATS
Ann R. Knebel, Ph.D.
Retired Deputy Scientific Director, Division of Preclinical Innovation, NCATS
Sui Huang, Ph.D.
Associate Professor, Cell and Developmental Biology, Northwestern University
Marc Ferrer, Ph.D.
Acting Director, Early Translation Branch, NCATS
Lectures
Open Opportunities
Translation at NCATS: A Brief Introduction to Our Research Program
(video length: 22:57)
Collaborative Discovery at NCATS Early Translation Branch ETB
(video length: 19:22)
Collaborative Discovery at NCATS Early Translation Branch ETB Part 2
(video length: 26:37)
Translational Science and Drug Development - Metarrestin
(video length: 10:56)
Identification of a Phenotypic Marker for Selective Anti Metastasis Drug Development
(video length: 24:48)
In vitro Assays for Drug Discovery and Development Towards Better Predictability
(video length: 22:58)
Using Phenotypic Based Drug Discovery and Development Towards Better Clinical Predictability
(video length: 30:34)
Resources
Download materials for this module:
- Module 2 Readings (PDF - 125KB)
- Module 2 Quiz (PDF - 81KB)
 |  | Except where otherwise noted, this work is licensed under https://creativecommons.org/licenses/by/4.0/ |